| Detailed Price Information Link | ||||||||||||||||||||
| BACTERIA |  How to read the following data (Example) | |||||||||||||||||||
| Name: | Acinetobacter baumannii Bouvet and Grimont 1986 | |||||||||||||||||||
| DSM No.: | 101650 dsm-101650 dsm101650 dsm 101650 Acinetobacter baumannii | |||||||||||||||||||
| Strain designation: | UKK-172 | |||||||||||||||||||
| Isolated from: | clinical isolate | |||||||||||||||||||
| Country: | Germany Cologne | |||||||||||||||||||
| Date of sampling: | before 10.11.2015 | |||||||||||||||||||
| Nagoya Protocol Restrictions: | There are NO known Nagoya Protocol restrictions for this strain. | |||||||||||||||||||
| History: | <- Institute for Medical Microbiology, Immunology and Hygiene, University of Cologne; | |||||||||||||||||||
| Cultivation conditions: | Medium 220 , 30°C Complete DSMZ Media List | |||||||||||||||||||
| Summary and additional information: | Clinical isolate. Germany, Cologne. Sampling Date: 01.08.2015. Clinical isolate, bacteriophage host .Host for phage vB_AbaM_Bhz33 = DSM 108600 . (Medium 220, 30°C) | |||||||||||||||||||
| Risk group: | 2 (classification according to German TRBA) | |||||||||||||||||||
| Restrictions: | Act dealing with the prevention & control of infectious diseases in man (Infektionsschutzgesetz), Category A1 | |||||||||||||||||||
| Supplied as: |
Freight and handling charges will be added. See price list. Note: Freight charges for Risk Group 2 microorganisms will apply. | |||||||||||||||||||
| Other cultures: | All DSMZ cultures of the species | |||||||||||||||||||
| Print data sheet | ||||||||||||||||||||
